Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Thrombotic thrombocytopenic purpura/hemolytic uremic syndrome relapse: frequency, pathogenesis, and meaning.

× No keyword cloud information.

13 in total

Review 1. Rituximab provided long-term remission in a patient with refractory relapsing thrombotic thrombocytopenic purpura.

Authors: Satoru Kosugi; Masanori Matsumoto; Yasushi Ohtani; Hironori Take; Hiromichi Ishizashi; Yoshihiro Fujimura; Jun Kuyama
Journal: Int J Hematol Date: 2005-06 Impact factor: 2.490

Review 2. Current concepts in thrombotic thrombocytopenic purpura.

Authors: Han-Mou Tsai
Journal: Annu Rev Med Date: 2006 Impact factor: 13.739

3. Clinical and laboratory patterns of the haemolytic uraemic syndrome and thrombotic thrombocytopenic purpura in southern Iran.

Authors: Mehran Karimi; Ameneh Sabzi; Flora Peyvandi; Pier Mannuccio Mannucci
Journal: Intern Emerg Med Date: 2006 Impact factor: 3.397

Review 4. Von Willebrand factor-cleaving protease and Upshaw-Schulman syndrome.

Authors: Yoshihiro Fujimura; Masanori Matsumoto; Hideo Yagi; Akira Yoshioka; Taei Matsui; Koiti Titani
Journal: Int J Hematol Date: 2002-01 Impact factor: 2.490

Review 5. Deficiency of ADAMTS13 in thrombotic thrombocytopenic purpura.

Authors: Han-Mou Tsai
Journal: Int J Hematol Date: 2002-08 Impact factor: 2.490

6. [Thrombotic thrombocytopenic purpura (Moschkowitz-syndrome) caused by ticlopidine].

Authors: J M Chemnitz; A Schulz; A Salameh; C Scheid; R Müller; A Draube; V Diehl; D Söhngen
Journal: Med Klin (Munich) Date: 2000-02-15

Review 7. Efficacy of rituximab in acute refractory or chronic relapsing non-familial idiopathic thrombotic thrombocytopenic purpura: a systematic review with pooled data analysis.

Authors: Nay M Tun; Gina M Villani
Journal: J Thromb Thrombolysis Date: 2012-10 Impact factor: 2.300

8. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura.

Authors: H M Tsai; E C Lian
Journal: N Engl J Med Date: 1998-11-26 Impact factor: 91.245

Review 9. The kidney in thrombotic thrombocytopenic purpura.

Authors: H-M Tsai
Journal: Minerva Med Date: 2007-12 Impact factor: 4.806

Review 10. Rituximab for chronic recurring thrombotic thrombocytopenic purpura: a case report and review of the literature.

Authors: Roslyn Yomtovian; Waldemar Niklinski; Bernard Silver; Ravindra Sarode; Han-Mou Tsai
Journal: Br J Haematol Date: 2004-03 Impact factor: 6.998